Table 2 Liver grading, tumors features, AFP and anti P53 findings in patient groups

Age (years)

51.9 ± 11.7

55.5 ± 6.2

53.1 ± 95

>0.05

>0.05

>0.05

Gender:

 - Male

185(76.45%)

37(94.87%)

15(75.00%)

>0.05

>0.05

>0.05

 - Female

57(23.55%)

2(05.13%)

4(20.00%)

>0.05

>0.05

>0.05

Severity of liver disease: Child-Pugh score

 - Class A

80(33.06%)

24(61.54%)

4(20.00%)

< 0.05*

>0.05

>0.05

 - Class B

48(19.83%)

9(23.08%)

7(35.00%)

>0.05

>0.05

>0.05

 - Class C

114(47.11%)

6(15.38%)

9(45.00%)

< 0.05*

>0.05

>0.05

(MELD score)

 - Early (6-11)

48(19.83%)

23(58.97%)

3(15.00%)

<0.001*

>0.05

<0.05*

 - Intermed.(12-18)

84(34.71%)

10(25.64%)

8(40.00%)

>0.05

>0.05

>0.05

 - Sever (19-40)

110(45.45%)

6(15.38%)

9(55.00%)

< 0.05*

>0.05

>0.05

Anti P53 antibody + ve

168(69.42%)

26(66.66%)

4(20.00%)

>0.05

< 0.05*

<0.05*

AFP (ng/mL)

 - <200

52(21.48%)

31(79.49%)

20(100%)

<0.001*

<0.001*

>0.05

 - 200-500

84(34.71%)

5(12.82%)

-

>0.05

< 0.05*

>0.05

 - >500

106(43.80%)

3(07.69%)

-

< 0.05*

< 0.05*

>0.05

Tumor findings US/CT

Size (cm):

 < 3

44(18.18%)

26(66.66%)

-

<0.001*

-

-

 3-5

98(40.50%)

9(23.08%)

-

>0.05

-

-

 >5

100(41.32%)

4(10.26%)

-

< 0.05*

-

-

Number of tumors:

 Single

148(61.16%)

33(84.62%)

-

>0.05

-

-

 Multiple

94(38.84%)

6(15.38%)

-

>0.05

-

-